Agilent Technologies and Ameritox Form Collaboration, Aim to Advance Analysis of Medication Monitoring
11 Feb 2013

Agilent Technologies Inc. and Ameritox today announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.

“By using multiple Rapid Fire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s Rapid Fire business.

While Agilent’s RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration with Ameritox is one of the first for Agilent’s RapidFire team in the field of medication monitoring.

“By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox.

“The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” Zimmerman said.

Request Info


Company website

Agilent RapidFire High-throughput MS
profile photo

Ami Miller
Life Science Editor  






Write a Review

Join 200,000 Scientists Online

Become a member for FREE access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today